Supplementation of Clostridium butyricum Alleviates Vascular Inflammation in Diabetic Mice
Diabetes & Metabolism Journal · 2024
DOI: 10.4093/dmj.2023.0109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, 2024. Verfasst von Tian Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Diagnostics, Tangdu Hospital, Air Force Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Clostridium butyricum, Gastrointestinal Microbiome, Diabetes Mellitus, Experimental, Inflammation. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Innovative Talent Promotion Program of Shaanxi Province, Aerospace Medical Research.
Abstract (Originalsprache)
Background
Gut microbiota is closely related to the occurrence and development of diabetes and affects the prognosis of diabetic complications, and the underlying mechanisms are only partially understood. We aimed to explore the possible link between the gut microbiota and vascular inflammation of diabetic mice.
Methods
The db/db diabetic and wild-type (WT) mice were used in this study. We profiled gut microbiota and examined the and vascular function in both db/db group and WT group. Gut microbiota was analyzed by 16s rRNA sequencing. Vascular function was examined by ultrasonographic hemodynamics and histological staining. Clostridium butyricum (CB) was orally administered to diabetic mice by intragastric gavage every 2 days for 2 consecutive months. Reactive oxygen species (ROS) and expression of nuclear factor erythroid-derived 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) were detected by fluorescence microscopy. The mRNA expression of inflammatory cytokines was tested by quantitative polymerase chain reaction.
Results
Compared with WT mice, CB abundance was significantly decreased in the gut of db/db mice, together with compromised vascular function and activated inflammation in the arterial tissue. Meanwhile, ROS in the vascular tissue of db/db mice was also significantly increased. Oral administration of CB restored the protective microbiota, and protected the vascular function in the db/db mice via activating the Nrf2/HO-1 pathway.
Conclusion
This study identified the potential link between decreased CB abundance in gut microbiota and vascular inflammation in diabetes. Therapeutic delivery of CB by gut transplantation alleviates the vascular lesions of diabetes mellitus by activating the Nrf2/HO-1 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound Diagnostics, Tangdu Hospital, Air Force Medical University, Xi'an, China.
- Department of Aerospace Medicine, Air Force Medical University, Xi'an, China.
- Department of Biochemistry and Molecular Biology, Air Force Medical University, Xi'an, China.
- Department of Ultrasound Diagnostics, The PLA Rocket Force Characteristic Medical Center, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Innovative Talent Promotion Program of Shaanxi Province
- Aerospace Medical Research
Zitieren
APA
Zhou, T., Qiu, S., Zhang, L., Li, Y., Zhang, J., Shen, D., Zhao, P., Yuan, L., Zhao, L., Duan, Y., & Xing, C. (2024). Supplementation of Clostridium butyricum Alleviates Vascular Inflammation in Diabetic Mice. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2023.0109
Vancouver
Zhou T, Qiu S, Zhang L, Li Y, Zhang J, Shen D, et al. Supplementation of Clostridium butyricum Alleviates Vascular Inflammation in Diabetic Mice. Diabetes & Metabolism Journal. 2024. doi:10.4093/dmj.2023.0109
BibTeX
@article{Zhou2024,
author = {Zhou, Tian and Qiu, Shuo and Zhang, Liang and Li, Yangni and Zhang, Jing and Shen, Donghua and Zhao, Ping and Yuan, Lijun and Zhao, Lianbi and Duan, Yunyou and Xing, Changyang},
title = {Supplementation of Clostridium butyricum Alleviates Vascular Inflammation in Diabetic Mice},
journal = {Diabetes & Metabolism Journal},
year = {2024},
doi = {10.4093/dmj.2023.0109}
}
EUVIMED